Lipid-modified immune response modifiers

Details for Australian Patent Application No. 2004266657 (hide)

Owner 3M Innovative Properties Company

Inventors Wightman, Paul D.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004266657

PCT Pub. Number WO2005/018555

Priority 60/544,561 13.02.04 US; 10/640,904 14.08.03 US; 60/515,604 30.10.03 US

Filing date 12 August 2004

Wipo publication date 3 March 2005

Acceptance publication date 2 July 2009

International Classifications

A61K 31/47 (2006.01) - Quinolines

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/018555 Priority application(s): WO2005/018555

2 July 2009 Application Accepted

  Published as AU-B-2004266657

29 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004266658-Hydroxylamine substituted imidazocontaining compounds

2004266654-Modular patient support system